MOHAMMED ASIRI
Riyadh
Summary
Dedicated clinical pharmacist with over 5 years of inpatient hospital experience, currently seeking an R3 Clinical Pharmacy Residency in Nephrology. Strong foundation in renal pharmacotherapy, dialysis-based dose adjustment, and transplant immunosuppression. Committed to advancing nephrology care through interdisciplinary collaboration, quality improvement, and research.
Overview
8
8
years of professional experience
1
1
Certification
Work History
Hospital Pharmacist
Prince Sultan Military Medical City
Riyadh
04.2018 - Current
- Delivered pharmaceutical care to renal, ICU, and internal medicine patients.
- Monitored and adjusted medications for chronic kidney disease, ESRD, and post-transplant patients.
- Reviewed prescriptions for renal dosing, nephrotoxicity, and drug interactions.
- Provided patient education on immunosuppressants and phosphate binders.
- Supervised IV admixture preparations and ensured compliance with CSP guidelines.
Residency Rotations
KFSHB,PSMMC
10.2023 - 10.2025
- Nephrology (Dr.Alanoud Alshannan) PSMMC : Participated in daily rounds for CKD, ESRD, and transplant patients; adjusted medication regimens based on CrCl and dialysis type; evaluated hyperkalemia, anemia, and mineral bone disease therapies.
- Internal Medicine(Dr.Huda Aldossari) PSMMC : Reviewed medication profiles, performed reconciliation, and optimized therapy for multimorbid patients.
- Intensive Care Unit (ICU)(Dr.Asma alshehri) PSMMC : Dosed medications in AKI, CRRT, and hemodynamic instability; monitored electrolytes and renal-related complications.
- Infectious Diseases(Dr.Wafa Alfahad) PSMMC : Applied renal dose adjustments for antimicrobials, contributed to ASP rounds, and reviewed culture-sensitivity reports.
- Cardiology(Dr.Salwa Al suhaibani) KFSHB : Managed heart failure and ACS patients with comorbid CKD; monitored anticoagulants and fluid balance.
- Transplantation(Dr.Sahar almowaina) PSMMC : Focused on immunosuppressive therapy for renal transplant patients; monitored drug levels, interactions, and rejection risk; provided discharge counseling and adherence education.
- Parenteral Nutrition (TPN)(Dr.Sohailah Alzahrani) PSMMC : Calculated and verified TPN formulas in patients with renal impairment; collaborated with dietitians on electrolyte and fluid management; ensured compatibility and aseptic preparation.
Education
Doctor of Pharmacy (PharmD)
King Khalid University – Abha, Saudi Arabia
05-2017
Skills
- Communications skills
- Literature review, clinical guideline application
- Scientific research skills
- Leadership and negotiation
- Planning and Organization
Certification
- Thinking Critically: Interpreting Randomized Clinical Trials – Stanford Medicine (May 2024)
- Infection Control and Prevention – Public Health Program (May 2024)
- Antimicrobial Stewardship: Improving Clinical Outcomes by Optimization of Antibiotic Practices – Stanford Medicine (Feb 2025)
- CDC’s Antibiotic Stewardship Courses – CDC (Apr 2025)
- Clinical Pharmacokinetics: Dosing and Monitoring – Taipei Medical University (May 2025)
- Research in Clinical Practice (RCP) Program – Saudi NIH (Ongoing)
Accomplishments
- Board Certified Pharmacotherapy Specialist (BCPS) – Board of Pharmacy Specialties, 2024
Research & Projects
- Pattern of Albumin Use at a Major Tertiary Hospital in Riyadh (Observational Study – May 2020)
Role: Data collection and statistical analysis. Findings led to revised ICU albumin prescribing protocol - Prescription of Antibiotics and Its Overuse Among Pediatric Dental Patients (Systematic Review – Oct 2022)
Conducted literature review and manuscript preparation; emphasized outpatient stewardship - Prevalence and Predictors of Augmented Renal Clearance (ARC) in Critically Ill Patients (Ongoing Project – 2025)
Currently leading a prospective observational study evaluating ARC incidence in ICU settings. Involves CrCl/MDRD comparison, regression analysis, and implications for renal dosing strategies
Presentations
- Journal Club:
Vancomycin Dosing in Hemodialysis Patients – Reviewed dosing strategies, PK/PD targets, and guideline-based recommendations.
AUGUSTUS Trial – Evaluated dual vs. triple antithrombotic therapy post-PCI in AF patients.
MERINO Trial – Assessed piperacillin-tazobactam vs. meropenem in ESBL bloodstream infections. - Case Presentations:
Calcineurin Inhibitor Nephrotoxicity in Renal Transplant – Diagnosis, management, and prevention.
Volume Overload and Resistant Hypertension in CKD – Optimizing diuretic strategies and RAS blockade.
Sepsis-Induced AKI with ARC – Antimicrobial dosing considerations in critically ill. - Clinical Topic Discussions (CTD):
Management of Hyperphosphatemia in CKD
Approach to Immunosuppressive Regimen in Renal Transplantation
Augmented Renal Clearance: Mechanisms and Clinical Relevance
Renal Dose Adjustment Principles Across Drug Classes
References
References available upon request.
Timeline
Residency Rotations
KFSHB,PSMMC
10.2023 - 10.2025
Hospital Pharmacist
Prince Sultan Military Medical City
04.2018 - Current
Doctor of Pharmacy (PharmD)
King Khalid University – Abha, Saudi Arabia
Similar Profiles
Nawaf AlzahraniNawaf Alzahrani
Pharmacy Intern at King Khalid University Hospital, Prince Sultan Military Medical City, Al-Dawaa Pharmacies, Servier Pharmaceuticals, KSU College of PharmacyPharmacy Intern at King Khalid University Hospital, Prince Sultan Military Medical City, Al-Dawaa Pharmacies, Servier Pharmaceuticals, KSU College of Pharmacy
ALFIE MARIE TULBAALFIE MARIE TULBA
Registered Nurse, Rehabilitation at Prince Sultan Military Medical CityRegistered Nurse, Rehabilitation at Prince Sultan Military Medical City
AMAL ALATWEIAMAL ALATWEI
PHLEBOTOMY SPECIALIST at Prince Sultan Military Medical CityPHLEBOTOMY SPECIALIST at Prince Sultan Military Medical City
Mohammed AlghamdiMohammed Alghamdi
Project coordinator at PRINCE SULTAN MILITARY MEDICAL CITYProject coordinator at PRINCE SULTAN MILITARY MEDICAL CITY
Mohammed Ali AltamimiMohammed Ali Altamimi
Director of the National Healthcare Strategy Depar at Saudi Health CouncilDirector of the National Healthcare Strategy Depar at Saudi Health Council